ERBB2 and breast cancer: These results are in line with those by Carr et al. [19], who conducted a retrospective analysis on 575 HR+/HER2– early BC patients, finding higher ER levels in pre-menopausal compared to post-menopausal patients, but comparable RS values in the two groups.